The Area of Major Interest (DIM) is the result of a structuring policy of the Paris Region, which aims to foster innovation by leveraging the excellence of Paris Region teams.
The DIM « thérapie génique » initiative was labelled in December 15th, 2016, among 8 other DIM.
Concretely, the DIM is a research network labelled for a time period of 4 years (2017-2020) by the Paris Region. This labelling allows research teams in the Paris Region to benefit from funding, based on an annual program defined by its members.
The DIM supports research projects by financing doctoral or postdoctoral fellowships and scientific equipment. The DIM also organizes scientific symposia and promotes the development of R&D partnerships with industry.